These results indicate CAF-derived CXCL16 as a critical regulator of TNFR2+ Treg accumulation and MPE progression, with conserved tumor-type effects suggesting suggesting broader implications in malignant progression. This evidence concerns the gene CXCL16 and neoplasm.